Tumor Ablation Market Size, Share & Trends Report

Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Percutaneous), By Application (Lung, Liver Cancer), By Technology (Radiofrequency, Microwave), And Segment Forecasts, 2018 - 2025

  • Published Date: Nov, 2018
  • Base Year for Estimate: 2017
  • Report ID: 978-1-68038-746-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 92

Industry Insights

The global tumor ablation market size was estimated at USD 933.5 million in 2017 and is expected to witness a CAGR of 11.12% over the forecast period. Increasing prevalence of cancer is the major factor contributing to market growth. Based on the statistics published by the World Health Organization (WHO), about 13.0% of the global population suffer from cancer. In addition, a 70.0% rise is expected in the disease prevalence over the next few decades.

Therefore, more than 100 cancer types require tumor ablation, thereby boosting market growth. Technological advancements in the field of thermal ablation technologies is anticipated to fuel market growth. Growing geriatric population is also likely to boost market growth.

North America tumor ablation market

According to WHO, an increase in global population is expected from 12.0% in 2015 to 22.0% in 2050. Thus, with increasing geriatric population, the demand for Minimally Invasive Surgeries (MIS) like radiofrequency ablation, is rising. Extensive usage of these procedures owing to their benefits, such as speedy recovery, less trauma, and minimal complications, is anticipated to boost the demand for tumor ablation technologies. Active role of healthcare agencies and government to create awareness about various types of cancer is further expected to accentuate the usage of this therapy.

Along with thermal ablation, techniques, such as laser ablation, irreversible electroporation, and High Intensity Focused Ultrasound (HIFU), are also gaining popularity, which, in turn, is supporting the tumor ablation market. Increasing per capita income, especially in developing regions, is also driving the market growth. Rise in disposable income levels is encouraging people to undergo advanced therapy for tumors, thus assisting market growth.

Technology Insights

On the basis of technology, the market has been segmented into microwave, radiofrequency, cryoablation, and other technologies, such as radio iodine, HIFU, and laser ablation. The radiofrequency technology held substantial market share in 2017. This technology uses imaging devices and needle electrode probe to pierce through skin. High frequency currents are passed through electrode for generating heat to destroy tumor cells.

Prominent application of this technology in solid tumor removal all over the body and its specificity contributed to its growth. Rising usage in solid tumor excision is also one of the prime factors responsible for its growth. Microwave ablation technology is anticipated to witness remunerative growth over the forecast period owing to benefits offered by this technology. Microwave ablation uses electromagnetic methods for tumor destruction with the device having frequencies of at least 900 MHz.

This method is advantageous over other techniques, in terms of effectiveness in treating tumor. It offers benefits, such as larger tumor ablation volume, consistency in high temperature, lesser time, reduced procedural pain, and optimal heating of the cystic mass. Furthermore, minimum procedure time (5-10 minutes), improved efficacy with minimal complications, and reduced hospital stay are expected to drive the growth of this segment.

Treatment Insights

On the basis of treatment, the market has been segmented into surgical, laparoscopic, and percutaneous procedures. Surgical segment held substantial share of 42.1% in 2015. Increased prevalence of liver and breast cancer, which require open surgical procedures, contributed to the segment growth.

On the other hand, percutaneous ablation has been anticipated to be the fastest growing segment. This advanced procedure involves treating tumors through skin. A small incision is made on skin through which radiofrequency probe is inserted, which terminates the tumor in target tissues. Quick surgery time, faster recovery, and patient comfort are high-impact rendering factors for the growth of this segment. Rising demand for minimally invasive surgeries is high-impact rendering factor contributing to the segment growth.

Application Insights

On the basis of application, the market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other types of cancer, such as bone metastasis, kidney, and ENT cancer. Availability of advanced methods and high prevalence of these cancers are anticipated to boost market growth. Liver cancer accounted for the largest market share in 2015. This type of cancer is most prominent in males than females.

Global tumor ablation market

Higher number of bile duct and primary liver cancer cases contributed to the segment growth. Lung cancer segment is anticipated to witness the highest CAGR during the forecast period. Rising prevalence of lung cancer types, such as Non-Small Cell Lung Cancer (NSCLC) is driving the segment. The NSCLC uses radiofrequency ablation and needle or probe to reach target cells and destroys tumor cells by generating heat. Local anesthesia is given sometimes when it is expected that patient would undergo trauma.

Regional Insights

North America led the overall market in 2017 accounting for over 34.0% of its share and is estimated to continue its dominance over the coming years. Major factors contributing to growth of this region include government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada.

For instance, in U.S., the Patient Protection and Affordable Care Act (PPACA), also known as ObamaCare, promotes quality and affordability of health insurance and reduces the cost of healthcare for individuals and government. Government initiatives, such as, Precision Medicine Initiative formulating tailored strategies on unique characteristics of diseases, are helping in improving the overall healthcare system, thus boosting market growth.

Europe accounted for about 24.0% of the global market share in the past. Greater extent of public funding in Europe’s healthcare system has contributed to this growth. Moreover, presence of target population base coupled with government support to control cancer led to substantial growth of this region. For instance, formation of bodies, such as the European Cancer Observatory, created awareness about cancer.

Asia Pacific is expected to witness lucrative growth over the forecast period owing to supportive government initiatives and improving healthcare infrastructure. Moreover, economic developments in countries, such as India and China, are expected to help spur the market growth. Huge population base with low per capita income in the region led to high demand for affordable treatment options.

Multinational companies are looking forward to investing in the developing countries of APAC. Thus, many collaborative partnerships and strategic alliances are taking place with companies in this region. All this factor will support the market growth.

Tumor Ablation Market Share Insights

Key companies in the global market are Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Angiodynamics; Covidien PLC; Boston Scientific Corporation; Medtronic Plc.; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc. These companies have adopted various strategies, such as new product launches, collaborations, technological advancements, M&A, to sustain their position in the market.

For instance, Covidien Plc acquired BARRX Medical Inc. leading to rights of Medtronic on the product Barrx Flex RFA System and other bipolar RF ablation devices. The acquisition led to generation of goodwill for the company, hence making the excessive price for the takeover fair. Similarly, Galil Medical Inc. launched a new family of cryoablation needles, IcePearl 2.1 CX, IceFORCE 2.1CX. Launch of these products is expected to strengthen the company’s product portfolio.

Report Scope

Attribute

Details

Base year for estimation

2017

Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million & CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Belgium, Switzerland, Poland, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global tumor ablation market report on the basis of technology, treatment, application, and region:

  • Technology Outlook (Revenue, USD Million, 2014 - 2025)

    • Radiofrequency

    • Microwave

    • Cryoablation

    • Irreversible Electroporation

    • Other Technologies

  • Treatment Outlook (Revenue, USD Million, 2014 - 2025)

    • Surgical

    • Laparoscopic

    • Percutaneous

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Prostate Cancer

    • Other Cancer

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Belgium

      • Switzerland

      • Poland

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified